Field MSL, Endocrinology – NYC

Recordati; New York (NY); Sur place; USD 160 000 - 220 000; Plein temps

Avantages offerts par ce poste

401(k) with company match

Medical, dental, and vision insurance

Mental health benefits

Paid time off and holidays

Life and AD&D insurance

Résumé du poste

Recordati Rare Diseases, Inc. (RRD) in North America is seeking a Medical Science Liaison (MSL) specializing in Endocrinology for the NYC area.

You will connect with opinion leaders, deliver scientific information, and support strategic medical initiatives for Isturisa, Signifor and Signifor LAR. You will build peer-to-peer collaborations, manage field insights, and present complex data to clinicians, KOLs, and advisory boards while complying with all regulatory requirements.

Qualifications

• Advanced scientific degree required (M.D., D.O., Ph.D., Pharm.D.).
• Minimum of two years in Medical Affairs/Clinical functions preferred.
• Familiarity with drug development, FDA, ICH, and GCP guidelines.

Responsabilités

• Deliver clinical and scientific presentations to healthcare professionals and committees.
• Provide scientific support at medical conferences with disease and product knowledge.
• Collaborate with physicians on medical affairs initiatives including publications and trials.
• Train staff on key scientific topics for relevant therapies.
• Develop and review medical content and presentations for internal and external audiences.

Connaissances

Presentation skills

Data interpretation

Medical affairs knowledge

Public speaking

Independent work

Formation

MD/DO/PhD/PharmD

Outils

Microsoft Office

Description du poste

Recordati Rare Diseases, Inc. (RRD) in North America is seeking a Medical Science Liaison (MSL) specializing in Endocrinology for the NYC area.

You will connect with opinion leaders, deliver scientific information, and support strategic medical initiatives for Isturisa, Signifor and Signifor LAR. You will build peer-to-peer collaborations, manage field insights, and present complex data to clinicians, KOLs, and advisory boards while complying with all regulatory requirements.